XML 55 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Tables)
12 Months Ended
Apr. 02, 2022
Fair Value Disclosures [Abstract]  
Fair value of financial assets and liabilities measured and recorded at fair value on recurring basis
The following table summarizes the Company's financial assets and liabilities that are measured and recorded at fair value on a recurring basis, excluding accrued interest components:
April 2,
2022
March 27,
2021
 (millions)
Derivative assets(a)
$32.4 $15.8 
Derivative liabilities(a)
18.3 55.4 
(a)Based on Level 2 measurements.
Carrying value and the estimated fair value of the Company's debt obligations
The following table summarizes the carrying values and the estimated fair values of the Company's debt instruments:
 April 2, 2022March 27, 2021
 
Carrying Value(a)
Fair Value(b)
Carrying Value(a)
Fair Value(b)
 (millions)
$400 million 3.750% Senior Notes$397.7 $407.9 $397.1 $443.4 
$500 million 1.700% Senior Notes499.8 500.5 498.4 507.8 
$750 million 2.950% Senior Notes738.8 721.0 737.4 779.4 
 
(a)See Note 11 for discussion of the carrying values of the Company's senior notes.
(b)Based on Level 2 measurements.
Fair value measurements, nonrecurring
The following tables summarize non-cash impairment charges recorded by the Company during the fiscal years presented to reduce the carrying values of certain long-lived assets to their estimated fair values as of the assessment date:
Fiscal Years Ended
April 2, 2022March 27, 2021March 28, 2020
Long-Lived Asset Category
Total Impairments(a)
Fair Value
as of Impairment Date
Total Impairments(a)
Fair Value
as of Impairment Date
Total Impairments(a)
Fair Value
as of Impairment Date
 (millions)
Property and equipment, net$1.0 $— $44.1 $23.5 $16.8 $2.4 
Operating lease right-of-use assets(b)
20.3 27.8 51.9 84.3 239.9 120.8 
Equity method investment
— N/A— N/A7.1 1.3 
 
(a)Impairment of equity method investment is recorded within other income (expense), net in the consolidated statements of operations. All other impairment charges are recorded within impairments of assets in the consolidated statements of operations, unless otherwise noted.
(b)Total impairment charges for Fiscal 2020 includes $225.1 million recorded in connection with the Company's adoption of ASU No. 2016-02, "Leases" as of the beginning of Fiscal 2020 which, net of related income tax benefits, reduced its opening retained earnings balance by $169.4 million.